Celon Pharma S.A. (8RP.F)
Frankfurt · EUR · Healthcare · Drug Manufacturers - Specialty & Generic
€4.06 (-1.10%) as of
Key statistics
- Market cap
- 218.88M
- P/E (TTM)
- 8.83
- EPS (TTM)
- 0.4600
- Dividend yield
- 0.00%
- 52-week range
- 4.0550 – 5.7700
- Beta
- 0.62
- Profit margin
- 41.46%
- Volume
- 100.00
About Celon Pharma S.A.
Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products. The company provides drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. Celon Pharma S.A. was founded in 2002 and is based in Lomianki, Poland. The company operates as a subsidiary of Glatton Sp. z o.o.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Lomianki, Poland
- Employees
- 560
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.